Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Maruzzo

Showing results (11-20 of 150) with videos related to

Pageof 15
Sort By:
Tumori|July 28, 2023
Role of enhancement modifications in evaluating tumor response to immunotherapy in metastatic renal cell carcinomaMichele Dionese, Francesco Pierantoni, Elisabetta Bezzon, et al.
Critical Reviews in Oncology/Hematology|December 10, 2021
High dose chemotherapy followed by autologous hematopoietic stem cell transplantation for advanced germ cell tumors: State of the art and a single-center experienceFrancesco Pierantoni, Marco Maruzzo, Davide Bimbatti, et al.
Frontiers in Oncology|July 25, 2019
Trabectedin Drug Holiday and Rechallenge in Soft Tissue Sarcomas: Report of 4 Cases and Literature ReviewFrancesco Pierantoni, Marco Maruzzo, Antonella Brunello, et al.
Critical Reviews in Oncology/Hematology|September 3, 2019
Immunotherapy and urothelial carcinoma: An overview and future prospectivesFrancesco Pierantoni, Marco Maruzzo, Mario Gardi, et al.
Frontiers in Oncology|April 2, 2021
Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical ParametersEvgeniya Sharova, Marco Maruzzo, Paola Del Bianco, et al.
Clinical Sarcoma Research|February 10, 2015
Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experienceMarco Maruzzo, Juan Martin-Liberal, Christina Messiou, et al.
Anti-Cancer Drugs|September 2, 2020
Fatal hyperprogression induced by nivolumab in metastatic renal cell carcinoma with sarcomatoid features: a case reportMichele Dionese, Francesco Pierantoni, Marco Maruzzo, et al.
Anticancer Research|September 30, 2024
Systemic Inflammation Indexes and Risk of Immune-related Adverse Events in Patients With Metastatic Urothelial Carcinoma Treated With ImmunotherapyMichele Dionese, Davide Bimbatti, Francesco Pierantoni, et al.
Journal of Geriatric Oncology|September 25, 2020
Comprehensive geriatric assessment is an independent prognostic factor in older patients with metastatic renal cell cancer treated with first-line Sunitinib or Pazopanib: a single center experienceFrancesco Pierantoni, Umberto Basso, Marco Maruzzo, et al.
Frontiers in Oncology|August 29, 2022
Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experienceDavide Bimbatti, Michele Dionese, Eleonora Lai, et al.
Pageof 15

Showing results (11-20 of 150) with videos related to

Sort By:
Pageof 15
Tumori|July 28, 2023
Role of enhancement modifications in evaluating tumor response to immunotherapy in metastatic renal cell carcinomaMichele Dionese, Francesco Pierantoni, Elisabetta Bezzon, et al.
Critical Reviews in Oncology/Hematology|December 10, 2021
High dose chemotherapy followed by autologous hematopoietic stem cell transplantation for advanced germ cell tumors: State of the art and a single-center experienceFrancesco Pierantoni, Marco Maruzzo, Davide Bimbatti, et al.
Frontiers in Oncology|July 25, 2019
Trabectedin Drug Holiday and Rechallenge in Soft Tissue Sarcomas: Report of 4 Cases and Literature ReviewFrancesco Pierantoni, Marco Maruzzo, Antonella Brunello, et al.
Critical Reviews in Oncology/Hematology|September 3, 2019
Immunotherapy and urothelial carcinoma: An overview and future prospectivesFrancesco Pierantoni, Marco Maruzzo, Mario Gardi, et al.
Frontiers in Oncology|April 2, 2021
Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical ParametersEvgeniya Sharova, Marco Maruzzo, Paola Del Bianco, et al.
Clinical Sarcoma Research|February 10, 2015
Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experienceMarco Maruzzo, Juan Martin-Liberal, Christina Messiou, et al.
Anti-Cancer Drugs|September 2, 2020
Fatal hyperprogression induced by nivolumab in metastatic renal cell carcinoma with sarcomatoid features: a case reportMichele Dionese, Francesco Pierantoni, Marco Maruzzo, et al.
Anticancer Research|September 30, 2024
Systemic Inflammation Indexes and Risk of Immune-related Adverse Events in Patients With Metastatic Urothelial Carcinoma Treated With ImmunotherapyMichele Dionese, Davide Bimbatti, Francesco Pierantoni, et al.
Journal of Geriatric Oncology|September 25, 2020
Comprehensive geriatric assessment is an independent prognostic factor in older patients with metastatic renal cell cancer treated with first-line Sunitinib or Pazopanib: a single center experienceFrancesco Pierantoni, Umberto Basso, Marco Maruzzo, et al.
Frontiers in Oncology|August 29, 2022
Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experienceDavide Bimbatti, Michele Dionese, Eleonora Lai, et al.
Pageof 15